OrganiGram Beats Revenue Estimates, Q4 Loss Beats Zacks Consensus Estimate

OrganiGram reported a Q4 loss of $0.2 per share, beating revenue estimates of $56.91 million, a 7.10% increase from the same period last year. The company has topped consensus revenue estimates three times over the last four quarters. OrganiGram shares have added 11.8% since the beginning of the year. The sustainability of the stock's price movement will depend on management's commentary on the earnings call.